Sk. Davis et al., DETERMINANTS OF CHOLESTEROL SCREENING AND TREATMENT PATTERNS - INSIGHTS FOR DECISION-MAKERS, American journal of preventive medicine, 15(3), 1998, pp. 178-186
Citations number
19
Categorie Soggetti
Medicine, General & Internal","Public, Environmental & Occupation Heath
Background: Adult cholesterol screening and treatment policies by the
National Cholesterol Education Program recommend that physicians scree
n all adults aged greater than or equal to 20. On the other hand, the
American College of Physicians recommends that healthy young adult men
aged >35 and premenopausal women aged >45 not be screened due to conc
erns about the cost of and health risks associated with overuse of pha
rmacologic therapy in lieu of lifestyle modification. Objectives: The
objectives of this study were to determine the type of treatment (life
style vs. pharmacologic) that physicians actually prescribe for indivi
duals screened for elevated cholesterol. Methods: Self-report data wer
e derived from the 1989-1990 cross-sectional survey of the Stanford Fi
ve-City Project on 1,883 Latino and Angle men and women aged 20 to '74
years of age. A four-stage sequential design was conducted using mult
iple stepwise regression analyses with a significance cut-point of P <
.01. Results: Young adult men and women were significantly less likel
y to report ever having been screened (OR 1.02; 95% CI 1.01-1.09). Ind
ividuals of low socioeconomic status (SES) were also significantly les
s likely to report ever being screened (OR, 1.12; CI, 1.08-1.16), as w
ere Latino men and women, regardless of age (OR 1.57; CI, 1.14-2.18).
There were no significant differences in the pattern of physician care
utilization among low SES or Latino individuals during the previous 1
2-month period. Among those under physician care to lower cholesterol,
young adults were more likely to be prescribed lifestyle modification
(OR, 0.95; CI, 0.92-0.98). Conclusions: Our results suggest that alth
ough young adults are less likely to be screened, if screened they are
more likely to be prescribed lifestyle modification than pharmacologi
c treatment for elevated cholesterol. The lower prevalence of screenin
g among low SES and Latino individuals suggests the need for policy di
scussions to reduce these disparities.